ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement
- Public sites
- 63
- Start date
- Jun 10, 2019
Lankenau Medical Center’s Structural Heart and Valvular Disease Program brings together cardiologists, imaging specialists, interventionalists and surgeons to evaluate and treat heart valve disease. Care includes minimally invasive and open aortic and mitral valve repair or replacement, TAVR, MitraClip transcatheter mitral repair, balloon valvuloplasty, paravalvular leak closure and other structural heart procedures.
This description was generated by AI based on public sources. Data Sources and Methodology · Report inaccurate information
Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis
ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial
The JenaValve ALIGN-AR Pivotal Trial
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Philadelphia, PA
Philadelphia, PA
Philadelphia, PA